The incidence of uveitis in patients with axial spondylarthritis treated with biologics or targeted synthetics: a systematic review and network meta-analysis.

Katie BechmanZijing YangMaryam A AdasDeepak NagraAli Soykan UguzlarMark D RussellNicky WilsonSophia SteerKatherine JonesJames Galloway

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2023)

Anti-TNF mAbs, JAKi and anti-IL17 appear protective against AU events in individuals with AxSpA, with no significant differences in risk of AU between treatments. This article is protected by copyright. All rights reserved.

Keyphrases

sensitive detection
rheumatoid arthritis
reduced graphene oxide
risk factors
juvenile idiopathic arthritis
ankylosing spondylitis
cancer therapy
gold nanoparticles
drug delivery
quantum dots